Olema Pharmaceuticals, Inc. · NASDAQ:OLMA
Logos Global Management LP reported a 4.70% stake in Olema Pharmaceuticals, Inc. (Schedule 13D/A)
Event Mar 18, 2025 · Filed May 13, 2025
Logos Global Management LP reported a 4.70% stake in Olema Pharmaceuticals, Inc., 3,208,875 shares, with active intent on Mar 18, 2025. Filed May 13, 2025 (Schedule 13D/A).
- Stake
- 4.70%
- Shares
- 3,208,875
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Logos Global Management LP | 4.70% | 3,208,875 |
| Logos Global Management GP LLC | 4.70% | 3,208,875 |
| Arsani William | 4.70% | 3,208,875 |
| Graham Walmsley | 4.70% | 3,208,875 |
| Logos Opportunities GP LLC | 1.00% | 708,114 |
| Logos GP LLC | 3.70% | 2,508,114 |
Source
Related
- Olema Pharmaceuticals, Inc.
- Logos Global Management LP
- Olema Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Bvf Partners L P · Oct 16, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Harmon Cyrus · Jul 27, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · May 15, 2026